Physical function · patients with rheumatoid arthritis
1 finding from 1 review
Intervention not reported
Quality of life on a 0 to 100 scale. Various quality of life scales. (higher score is better)
1 finding from 1 review
Function ‐ measured as KSS function Knee Society Score, function. Scale from 0 to 100 (higher scores indicates better function) · patients with posterior cruciate retaining total knee arthroplasty for postoperative functional status in patients with osteoarthritis and…
1 finding from 1 review
Health‐related quality of life (physical) · patients with posterior cruciate retaining total knee arthroplasty for postoperative functional status in patients with osteoarthritis and…
1 finding from 1 review
Total active extension at 3 months Major outcome group 3 (early objective measurement) Total active extension (TAE) of MCPJ, PIPJ and DIPJ; higher value indicates loss of extension and a worse outcome · 210 participants with Dupuytren's disease of the fingers in 2 studies (225 digits reported across all studies) (Collis 2013;…
1 finding from 1 review
Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with axSpA (AS and nr‐axSpA)
1 finding from 1 review
no estimate extracted
850 participants
High
BASDAI Scale from 0 to 100 (higher is worse) · patients with axSpA (AS and nr‐axSpA)
1 finding from 1 review
no estimate extracted
193 participants
Moderate
BASFI Scale from 0 to 100 (higher is worse) · patients with axSpA (AS and nr‐axSpA)
1 finding from 1 review
no estimate extracted
349 participants
High
BASMI Scale from 0 to 10 (higher is worse) · patients with axSpA (AS and nr‐axSpA)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Radiographic progression · patients with axSpA (AS and nr‐axSpA)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
BASDAI Scale from 0 to 100 (higher is worse) · patients with axSpA (AS and nr‐axSpA)
1 finding from 1 review
no estimate extracted
190 participants
Moderate
BASFI Scale from 0 to 100 (higher is worse) · patients with axSpA (AS and nr‐axSpA)
1 finding from 1 review
no estimate extracted
356 participants
High
BASMI Scale from 0 to 10 (higher is worse) · patients with axSpA (AS and nr‐axSpA)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Radiographic progression · patients with axSpA (AS and nr‐axSpA)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with axSpA (AS and nr‐axSpA)
1 finding from 1 review
no estimate extracted
349 participants
High
Intervention not reported
Pain Global pain 0‐3 (higher scores mean worse) · patients with treating osteoarthritis
1 finding from 1 review
Intervention not reported
Pain Global pain VAS 0‐100 (higher scores mean worse) · patients with treating osteoarthritis
1 finding from 1 review
Intervention not reported
Function Loss of function 0‐3 (higher scores mean worse) · patients with treating osteoarthritis
1 finding from 1 review
Intervention not reported
Pain Global pain VAS 0‐100 (higher scores mean worse) · patients with treating osteoarthritis
1 finding from 1 review
Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with treating osteoarthritis
1 finding from 1 review